4/A//SEC Filing
IDEXX LABORATORIES INC /DE 4/A
Accession 0000874716-03-000075
$IDXXCIK 0000874716operating
Filed
Jul 29, 8:00 PM ET
Accepted
Jul 30, 12:21 PM ET
Size
6.0 KB
Accession
0000874716-03-000075
Insider Transaction Report
Form 4/AAmended
GOOD MARY L PHD
Director
Transactions
- Award
Common Stock
2003-07-01$34.89/sh+107$3,733→ 107 total
Footnotes (2)
- [F1]Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the "Plan") in accordance with Rule 16b-3. The number of deferred stock units acquired is determined by dividing the amount of the Director's cash fees deferred pursuant to the Plan ($3,750) by the closing price of the IDEXX Laboratories, Inc. Common Stock on the date of the deferral. Deferred stock untis are issuable only as common stock on a one-for-one basis one year following the Director's resignation from the Board of Directors.
- [F2]Reporting person indirectly holds 4,796 shares of common stock, which are held by Good Family Associates LP, as to which Dr. Good shares voting and dispositive power.
Documents
Issuer
IDEXX LABORATORIES INC /DE
CIK 0000874716
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000874716
Filing Metadata
- Form type
- 4/A
- Filed
- Jul 29, 8:00 PM ET
- Accepted
- Jul 30, 12:21 PM ET
- Size
- 6.0 KB